|
Atomistry » Manganese » PDB 5hzz-5jpf » 5ji6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Manganese » PDB 5hzz-5jpf » 5ji6 » |
Manganese in PDB 5ji6: Potent, Reversible METAP2 Inhibitors Via FbddEnzymatic activity of Potent, Reversible METAP2 Inhibitors Via Fbdd
All present enzymatic activity of Potent, Reversible METAP2 Inhibitors Via Fbdd:
3.4.11.18; Protein crystallography data
The structure of Potent, Reversible METAP2 Inhibitors Via Fbdd, PDB code: 5ji6
was solved by
D.R.Dougan,
J.D.Lawson,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 5ji6:
The structure of Potent, Reversible METAP2 Inhibitors Via Fbdd also contains other interesting chemical elements:
Manganese Binding Sites:
The binding sites of Manganese atom in the Potent, Reversible METAP2 Inhibitors Via Fbdd
(pdb code 5ji6). This binding sites where shown within
5.0 Angstroms radius around Manganese atom.
In total 2 binding sites of Manganese where determined in the Potent, Reversible METAP2 Inhibitors Via Fbdd, PDB code: 5ji6: Jump to Manganese binding site number: 1; 2; Manganese binding site 1 out of 2 in 5ji6Go back to Manganese Binding Sites List in 5ji6
Manganese binding site 1 out
of 2 in the Potent, Reversible METAP2 Inhibitors Via Fbdd
Mono view Stereo pair view
Manganese binding site 2 out of 2 in 5ji6Go back to Manganese Binding Sites List in 5ji6
Manganese binding site 2 out
of 2 in the Potent, Reversible METAP2 Inhibitors Via Fbdd
Mono view Stereo pair view
Reference:
Z.Cheruvallath,
M.Tang,
C.Mcbride,
M.Komandla,
J.Miura,
T.Ton-Nu,
P.Erikson,
J.Feng,
P.Farrell,
J.D.Lawson,
D.Vanderpool,
Y.Wu,
D.R.Dougan,
A.Plonowski,
C.Holub,
C.Larson.
Discovery of Potent, Reversible METAP2 Inhibitors Via Fragment Based Drug Discovery and Structure Based Drug Design-Part 1. Bioorg.Med.Chem.Lett. V. 26 2774 2016.
Page generated: Sun Oct 6 01:32:01 2024
ISSN: ESSN 1464-3405 PubMed: 27155900 DOI: 10.1016/J.BMCL.2016.04.073 |
Last articlesZn in 9JYWZn in 9IR4 Zn in 9IR3 Zn in 9GMX Zn in 9GMW Zn in 9JEJ Zn in 9ERF Zn in 9ERE Zn in 9EGV Zn in 9EGW |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |